The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Safety and efficacy of combination olaparib (O) and temozolomide (T) in small cell lung cancer (SCLC).
 
Anna F. Farago
Honoraria - Foundation Medicine
Consulting or Advisory Role - Abbvie; Intervention Insights; Loxo; Merrimack; PharmaMar; Takeda
Research Funding - Abbvie (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Ignyta (Inst); Loxo (Inst); Merck (Inst); PharmaMar (Inst)
Travel, Accommodations, Expenses - Abbvie; Abbvie/Stemcentrx; PharmaMar
 
Benjamin Jacob Drapkin
No Relationships to Disclose
 
Allison Charles
No Relationships to Disclose
 
Beow Y Yeap
No Relationships to Disclose
 
Rebecca Suk Heist
Consulting or Advisory Role - Boehringer Ingelheim
Research Funding - Abbvie (Inst); Celgene (Inst); Corvus Pharmaceuticals (Inst); Debiopharm Group (Inst); Exelixis (Inst); Incyte (Inst); Millennium (Inst); Mirati Therapeutics (Inst); Novartis (Inst); Peregrine Pharmaceuticals (Inst); Roche (Inst)
 
Christopher G. Azzoli
Consulting or Advisory Role - ARIAD/Takeda; Merck
 
David Michael Jackman
Consulting or Advisory Role - Bayer; Celgene; CVS Caremark; Genentech; Lilly
 
J Paul Marcoux
No Relationships to Disclose
 
David Allen Barbie
Consulting or Advisory Role - N-of-One
 
David T. Myers
No Relationships to Disclose
 
Sarah Phat
No Relationships to Disclose
 
Jun Zhong
No Relationships to Disclose
 
Jane Bailey Grinnell
No Relationships to Disclose
 
Lecia V. Sequist
Honoraria - AstraZeneca
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Genentech/Roche; Pfizer
Research Funding - AstraZeneca (Inst); Boehringer Ingelheim (Inst); Clovis Oncology (Inst); Genentech (Inst); Guardant Health (Inst); Incyte (Inst); Johnson & Johnson (Inst); Merck (Inst); Merrimack (Inst); Novartis (Inst); Pfizer (Inst)
 
Mari Mino-Kenudson
Consulting or Advisory Role - H3 Biomedicine; Merrimack
 
Shyamala Maheswaran
No Relationships to Disclose
 
Daniel A. Haber
No Relationships to Disclose
 
Aaron N. Hata
Research Funding - Amgen; Novartis; Relay Therapeutics
 
Nicholas John Dyson
Research Funding - AstraZeneca (Inst); Novartis (Inst)
 
Alice Tsang Shaw
Honoraria - Foundation medicine; Novartis; Pfizer; Roche/Genentech
Consulting or Advisory Role - ARIAD; Blueprint Medicines; Daiichi Sankyo; EMD Serono; Genentech; Ignyta; KSQ Therapeutics; Loxo; Natera; Novartis; Pfizer; Roche; Taiho Pharmaceutical; Takeda
Research Funding - Novartis; Pfizer; Roche/Genentech